… drug costs, defined in this analysis as the difference in total drug price between the novel
anticancer drugs … how the incremental overall drug costs of cancer treatments are changing. …

… In February 2006, 9 years after the drug received its initial Food and Drug Administration (…
developed serious viral infections after treatment with the drug. Infections included hepatitis B, …

As a group of more than 100 experts in chronic myeloid leukemia (CML), we draw attention
to the high prices of cancer drugs, with the particular focus on the prices of approved tyrosine …

Thalidomide (Thal) can overcome drug resistance in multiple myeloma (MM) but is associated
with somnolence, constipation, and neuropathy. In previous in vitro studies, we have …

… drugs solely to pharmaceutical companies could bankrupt our health care system and Medicare
and is unfair to our society and … Although many approaches can be taken to reduce drug …

… survive initial exposures to cytotoxic drugs and eventually select for drug-resistant populations.
… drug exposure may differ from drug resistance mechanisms selected for by chronic drug …

… Both in the recent American Society of Clinical Oncology (ASCO) … drugs. Different models
to judge the appropriateness of prescribing drugs have been proposed; the European Society …

… drug resistance of human multiple myeloma cells to conventional therapy | Blood | American
Society of … Drug-resistant cell lines were cultured with either Dox, Mit, Mel, or Dex to confirm …

… chemotherapy drug intensity. Physicians now have access to an increasing number of drugs
with novel … Key issues faced by hematologists in this era of new drugs include (1) the timely …

… reported to have a drug-induced etiology, and many different drugs have been suspected
as a … of a drug with TMA and systematically searched for all published reports of drug-induced …